P08254 (MMP3_HUMAN) Homo sapiens (Human)

Stromelysin-1 UniProtKBInterProSTRINGInteractive Modelling

477 aa; Sequence (Fasta)

Available Structures

44 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
MMP-3/TIMP-1 COMPLEX Heteromer
P01033;
100-267
ZN;CA;
Assess
Orientation in Solution of MMP-3 Catalytic Domain and N-TIMP-1 from Residual Dipolar Couplings Heteromer
P01033;
100-267
Assess
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66S/E67Y/L133N/S155L) wi… Heteromer
P01033;
100-264
CA;ZN;CL;TRS;SO4;GOL;ACT;
Assess
Complex of tissue inhibitor of metalloproteinase-1 (TIMP-1) mutant L34G with matrix metalloproteina… Heteromer
P01033;
104-264
CA;ZN;
Assess
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/L133P/L151C/G154A) with m… Heteromer
P01033;
104-264
CA;ZN;
Assess
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66D/T98G/P131S/Q153N) wi… Heteromer
P01033;
105-264
CA;ZN;
Assess
CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYMEhomo-2-mer33-267
ZN;CA;
Assess
HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812homo-2-mer100-272
ZN;CA;TR1;
Assess
CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.homo-2-mer100-272
ZN;CA;SPC;
Assess
DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORShomo-2-mer100-272
ZN;CA;N25;
Assess
STROMELYSIN-1homo-2-mer100-272
ZN;CA;S27;
Assess
DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORShomo-2-mer100-272
ZN;CA;S80;
Assess
HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812homo-2-mer103-269
ZN;CA;TR1;
Assess
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CA…homo-2-mer105-264
ZN;CA;L04;
Assess
CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITORmonomer100-272
ZN;8MI;
Assess
SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDI…monomer100-272
ZN;CA;HAV;3MP;MSB;
Assess
Stromelysin-1 (MMP-3) complexed to a hydroxamic acid inhibitormonomer100-270
ZN;CA;FA4;
Assess
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3monomer100-268
ZN;CA;
Assess
CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTIONmonomer100-268
ZN;CA;
Assess
CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.monomer100-268
ZN;CA;
Assess
CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITORmonomer100-268
ZN;CA;
Assess
HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTSmonomer100-268
ZN;CA;
Assess
CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.monomer100-268
ZN;CA;MM3;
Assess
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3monomer100-267
ZN;CA;
Assess
X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLIC…monomer100-267
ZN;CA;SO4;DPS;
Assess
X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLIC…monomer100-267
ZN;CA;SO4;DPS;
Assess
Structure of MMP3 complexed with NNGH inhibitor.monomer100-267
ZN;CA;
Assess
Structure of MMP3 complexed with a platinum-based inhibitormonomer100-267
ZN;CA;PT;CL;
Assess
Structure of MMP3 complexed with a platinum-based inhibitor.monomer100-267
ZN;CA;PT;
Assess
X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysinmonomer100-267
ZN;CA;HQQ;
Assess
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CA…monomer100-267
ZN;CA;8MI;
Assess
STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE …monomer100-267
ZN;CA;ATT;
Assess
X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLIC…monomer100-266
ZN;CA;SO4;IN7;
Assess
catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methoxy-N-(pyridine-3-ylmethyl)phe…monomer100-266
CA;ZN;OHL;SO4;
Assess
catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methylphenylsulfonamido)acetamidemonomer100-266
CA;ZN;Z79;SO4;
Assess
Stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% ace…monomer100-265
ZN;CA;0DS;
Assess
STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACE…monomer100-265
ZN;CA;0DS;
Assess
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZ…monomer100-264
ZN;CA;IN9;
Assess
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZ…monomer100-264
ZN;CA;IN8;
Assess
CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAINmonomer106-267
ZN;CA;
Assess
CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAINmonomer106-266
ZN;CA;
Assess
Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of N-isobutyl-N-[4-methoxy…monomer105-265
ZN;CA;NGH;
Assess
solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of n-hydroxy-2-[n-(2-hydro…monomer105-265
ZN;CA;JT5;
Assess
Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of 3-4'-cyanobyphenyl-4-yl…monomer105-265
ZN;CA;JT6;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1su3.1.Amonomer0.7432-477
ZN;56.16
Assess
3ba0.1.Amonomer0.70107-477
ZN;HAE;52.89
Assess